Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 16.1
(6.62%)
ILA 16.1
(6.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 51.74 Million USD | 8382.3% |
| 2022 | 610 Thousand USD | 21.03% |
| 2021 | 504 Thousand USD | -16.69% |
| 2020 | 605 Thousand USD | 28.72% |
| 2019 | 470 Thousand USD | -48.8% |
| 2018 | 918 Thousand USD | 35.6% |
| 2017 | 677 Thousand USD | 22.42% |
| 2016 | 553 Thousand USD | -4.33% |
| 2015 | 578 Thousand USD | -44.15% |
| 2014 | 1.03 Million USD | 19.65% |
| 2013 | 865 Thousand USD | -0.92% |
| 2012 | 873 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 127.5 Thousand USD | 0.0% |
| 2024 Q1 | 127.5 Thousand USD | -99.5% |
| 2023 Q4 | 25.74 Million USD | 236.73% |
| 2023 FY | 18.12 Million USD | 2871.48% |
| 2023 Q1 | 1.41 Million USD | 170.54% |
| 2023 Q2 | 1.41 Million USD | 0.0% |
| 2023 Q3 | 7.64 Million USD | 438.69% |
| 2022 Q4 | 524.5 Thousand USD | 0.0% |
| 2022 FY | 610 Thousand USD | 21.03% |
| 2022 Q3 | 524.5 Thousand USD | -74.7% |
| 2022 Q2 | 2.07 Million USD | 0.0% |
| 2022 Q1 | 2.07 Million USD | -60.67% |
| 2021 Q1 | 126 Thousand USD | 31.25% |
| 2021 Q4 | 5.27 Million USD | 0.0% |
| 2021 Q2 | 137 Thousand USD | 8.73% |
| 2021 Q3 | 5.27 Million USD | 3747.45% |
| 2021 FY | 504 Thousand USD | -16.69% |
| 2020 FY | 605 Thousand USD | 28.72% |
| 2020 Q1 | 274 Thousand USD | 119.2% |
| 2020 Q4 | 96 Thousand USD | -18.64% |
| 2020 Q3 | 118 Thousand USD | 0.85% |
| 2020 Q2 | 117 Thousand USD | -57.3% |
| 2019 Q4 | 125 Thousand USD | -3.1% |
| 2019 Q1 | 88 Thousand USD | -42.86% |
| 2019 Q2 | 128 Thousand USD | 45.45% |
| 2019 Q3 | 129 Thousand USD | 0.78% |
| 2019 FY | 470 Thousand USD | -48.8% |
| 2018 FY | 918 Thousand USD | 35.6% |
| 2018 Q4 | 154 Thousand USD | -12.99% |
| 2018 Q3 | 177 Thousand USD | -59.5% |
| 2018 Q2 | 437 Thousand USD | 191.33% |
| 2018 Q1 | 150 Thousand USD | -84.79% |
| 2017 Q3 | 986 Thousand USD | -53.23% |
| 2017 Q1 | 2.1 Million USD | 1395.03% |
| 2017 Q2 | 2.1 Million USD | 0.0% |
| 2017 FY | 677 Thousand USD | 22.42% |
| 2017 Q4 | 986 Thousand USD | 0.0% |
| 2016 Q1 | 144 Thousand USD | -8.86% |
| 2016 Q3 | 122 Thousand USD | -16.44% |
| 2016 Q2 | 146 Thousand USD | 1.39% |
| 2016 Q4 | 141 Thousand USD | 15.57% |
| 2016 FY | 553 Thousand USD | -4.33% |
| 2015 Q3 | 126 Thousand USD | -21.25% |
| 2015 Q1 | 134 Thousand USD | -91.93% |
| 2015 Q4 | 158 Thousand USD | 25.4% |
| 2015 Q2 | 160 Thousand USD | 19.4% |
| 2015 FY | 578 Thousand USD | -44.15% |
| 2014 Q2 | 3.63 Million USD | 37.96% |
| 2014 Q4 | 1.65 Million USD | 196.96% |
| 2014 Q3 | 559 Thousand USD | -84.6% |
| 2014 Q1 | 2.63 Million USD | 169.4% |
| 2014 FY | 1.03 Million USD | 19.65% |
| 2013 Q2 | 1.75 Million USD | -34.65% |
| 2013 FY | 865 Thousand USD | -0.92% |
| 2013 Q4 | 976.99 Thousand USD | -47.02% |
| 2013 Q3 | 1.84 Million USD | 5.01% |
| 2013 Q1 | 2.68 Million USD | 0.0% |
| 2012 FY | 873 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|